Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China.

BACKGROUND: On January 20, 2020, a new coronavirus epidemic with human-to-human transmission was officially declared by the Chinese government, which caused significant public panic in China. In light of the coronavirus disease 2019 outbreak, pregnant women may be particularly vulnerable and in special need for preventive mental health strategies. Thus far, no reports exist to investigate the mental health response of pregnant women to the coronavirus disease 2019 outbreak.
OBJECTIVE: This study aimed to examine the impact of coronavirus disease 2019 outbreak on the prevalence of depressive and anxiety symptoms and the corresponding risk factors among pregnant women across China. STUDY
DESIGN: A multicenter, cross-sectional study was initiated in early December 2019 to identify mental health concerns in pregnancy using the Edinburgh Postnatal Depression Scale. This study provided a unique opportunity to compare the mental status of pregnant women before and after the declaration of the coronavirus disease 2019 epidemic. A total of 4124 pregnant women during their third trimester from 25 hospitals in 10 provinces across China were examined in this cross-sectional study from January 1, 2020, to February 9, 2020. Of these women, 1285 were assessed after January 20, 2020, when the coronavirus epidemic was publicly declared and 2839 were assessed before this pivotal time point. The internationally recommended Edinburgh Postnatal Depression Scale was used to assess maternal depression and anxiety symptoms. Prevalence rates and risk factors were compared between the pre- and poststudy groups.
RESULTS: Pregnant women assessed after the declaration of coronavirus disease 2019 epidemic had significantly higher rates of depressive symptoms (26.0% vs 29.6%, P=.02) than women assessed before the epidemic declaration. These women were also more likely to have thoughts of self-harm (P=.005). The depressive rates were positively associated with the number of newly confirmed cases of coronavirus disease 2019 (P=.003), suspected infections (P=.004), and deaths per day (P=.001). Pregnant women who were underweight before pregnancy, primiparous, younger than 35 years, employed full time, in middle income category, and had appropriate living space were at increased risk for developing depressive and anxiety symptoms during the outbreak.
CONCLUSION: Major life-threatening public health events such as the coronavirus disease 2019 outbreak may increase the risk for mental illness among pregnant women, including thoughts of self-harm. Strategies targeting maternal stress and isolation such as effective risk communication and the provision of psychological first aid may be particularly useful to prevent negative outcomes for women and their fetuses.

Introduction

Several clusters of individuals with pneumonia of unknown etiology in Wuhan, Hubei province, China, were reported to the Chinese health authorities starting from December 8, 2019. The pathogen was identified as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the World Health Organization declared the virus outbreak a public health emergency of international concern. At the beginning of the outbreak, much remained unknown except that it was transmitted by direct exposure at a local animal market. Information on person-to-person transmission of the coronavirus disease 2019 (COVID-19) was revealed by the government to the Chinese public on January 20, 2020 and that asymptomatic individuals were potential sources of infection. , The number of identified cases continued to increase as did the public panic and flow of misinformation.

Why was this study conducted?

A crisis such as the coronavirus disease 2019 outbreak is a major public health event that causes significant uncertainty and isolation. The negative impact may be even greater among pregnant women who have increased stress owing to concerns for their fetus.

Key findings

An increase in the prevalence of depressive and anxiety symptoms was found after the declaration of coronavirus disease 2019 human-to-human transmission. Pregnant women also reported having significantly more thoughts of self-harm. Women at increased risk for depression after the crisis declaration included those who were primiparous, younger than 35 years, underweight before pregnancy, employed full time, in middle income category, and had a per capita living area of ≥20 m2 and decreased physical activity.

What does this add to what is known?

Major public health emergencies may increase the depression and anxiety levels in pregnant women.

To date, epidemiologic data on the mental health problems of the general population during the COVID-19 outbreak have not been available and how to best respond to challenges during the outbreak remains unknown. Those in quarantine often experience boredom, loneliness, and anger, in addition, the virus has been repeatedly described as a killer virus on social media, perpetuating a sense of danger and uncertainty among the public. In the early phase of the 2003 SARS outbreak, a range of psychiatric morbidities, including persistent depression, anxiety, panic attacks, psychotic symptoms, and even suicidality, were reported. , Mandatory contact tracing and 14-day quarantine, which form part of the public health responses to the COVID-19 outbreak, increased anxiety, feelings of isolation, and stigma. ,

One particularly vulnerable group during a viral outbreak may be pregnant women. Mental health disorders are a common cause of morbidity during pregnancy with approximately 12% of women experiencing depression and up to 22% experiencing high levels of anxiety in late pregnancy. , Pregnant women are more vulnerable to infections because of their naturally suppressed immune system and are generally considered at increased risk for severe complications. Moreover, pregnant women may be further vulnerable to anxiety due to increased concern about vertical transmission to their fetus. To date, the mental health response of pregnant women to the COVID-19 outbreak has not been investigated. This study aimed to examine the impact of the COVID-19 outbreak on the prevalence of depression and anxiety and the corresponding risk factors during pregnancy.

Materials and Methods

Study design and data collection

Human-to-human transmission of COVID-19 was first confirmed and reported by the Chinese government on January 20, 2020. In early December 2019 before the COVID-19 outbreak, our team initiated a multicenter cross-sectional study to identify mental health concerns in pregnancy using the Edinburgh Postnatal Depression Scale (EPDS). This study provided a unique opportunity to compare the mental status of pregnant women before and after the declaration of the COVID-19 epidemic. To examine the effect of a major public health emergency on the mental health of pregnant women, data from January 1, 2020, to February 9, 2020, were obtained from the Perinatal and Postpartum Depression Information Collection System we created. For this study, all participants were categorized into 2 groups based on whether human-to-human transmission of COVID-19 had been reported when the study questionnaire was completed (group 1, before the declaration of human-to-human transmission; group 2, after the declaration). Information of the number of suspected, confirmed, and death cases of COVID-19 in China were obtained after the declaration made on January 20, 2020. This study was registered to the Chinese Clinical Trial Registry (ChiCTR1900027020), and the ethical approval was obtained from the institutional review board of International Peace Maternity and Child Health Hospital (GKLW2019-11). Informed consent was obtained from all participants.

Participants

This cross-sectional study was performed in 25 public hospitals from 10 provinces across China, covering the East, the Middle, the Northwest, the Northeast, and the South. Pregnant women in their third trimester of pregnancy were invited to complete a study questionnaire by a trained research assistant during their regular obstetrical clinic visit. Questions pertained to sociodemographic characteristics, lifestyles, reproductive history, history of mental health problems, current depressive symptoms, marital and family support, and pregnancy complications (threatened abortion, gestational diabetes mellitus, hypertensive disorder, placenta previa, intrahepatic cholestasis of pregnancy, oligohydramnios, and intrauterine growth restriction).

Assessment criteria

Depressive symptoms were measured by EPDS, the most frequently used and internationally recommended screening measure for perinatal depression. , EPDS was used to evaluate feelings in the last 7 days with a recommended cutoff score of 10 or higher to detect possible depression during community-based screening. , In this study, a cutoff score of 10 or higher was used to analyze group differences in depression because this lower cutoff score is recommended for Asian population. In addition to depression, EPDS may be used to assess anxiety symptoms. The accumulative score from the items 3, 4, and 5 in EPDS (EPDS-3A) represents the anxiety dimension. ,

Statistical analysis

All analyses were conducted with R statistical software version 3.6.2 (packages rms, ggplot2, ggradar, nCOV2019, recharts). All reported probability values were 2-tailed, and the criterion for significance was set at P=.05. Univariate statistics and distribution were assessed; continuous variables were presented as means and standard deviations or median and interquartile ranges (IQRs). Categorical variables were expressed as frequency and percentage. The crude prevalence of depressive symptoms was displayed from January 1, 2020, to February 9, 2020. The chi-square test was used for categorical variables. Mann-Whitney U tests were applied to continuous variables with a non-normal distribution. We investigated the association between the number of changes per day (confirmed COVID-19 cases, suspected cases, or death cases) and EPDS scores using ordinary least squares linear regression models. We also investigated the risk for depression (EPDS≥10) using logistic regression models. The analyses were adjusted for potential confounders such as age, body mass index (BMI), education levels, occupation, annual household income, parity, investigation site, family support, per capita living area, maternal only-child status, pregnancy complications, and exercise level. Ordinal logistic regression model was used for a response variable with each EPDS items and with explanatory factors. Further model assumptions were assessed by plotting model residuals and evaluating R 2/sum of squared residuals.

We performed a subgroup analysis to investigate whether the increased risk for depressive symptoms was associated with the declaration of the COVID-19 epidemic using radar plot and attributable risk proportion and 95% confidence intervals (CIs). To further examine risk factors, we examined COVID-19–related factors, baseline variables, and pregnancy complications using logistic regression. The parameters included COVID-19 epidemic declaration, education levels, occupation, annual household income, family support, per capita living area, maternal only-child status, placenta previa, and exercise. We also considered investigation sites, history of diseases, use of assisted reproductive technology (ART), and twin pregnancy as potential confounders, but adjustment for these variables did not change the results and therefore were not include in the final models. We did not use imputing data analyses due to no missing data.

Results

Sample characteristics

A total of 4124 pregnant women were included in the analysis, 2839 of whom were investigated before January 21, 2020 (group 1). The distribution of demographic characteristics, including geographic region, was similar between the 2 study groups (Table 1 ). Owing to the small proportion of women with a history of anxiety or depression (<1%), we did not exclude them in the following analyses.

Table 1

Group baseline characteristics

Characteristic	Group 1 (n=2839)	Group 2 (n=1285)a
	Jan. 1–20	Jan. 21 to Feb. 9
	n (%)	n (%)
Age, median (range) y	30 (27–32)	30 (27–32)
Age groups
<35 y	2461 (86.7)	1097 (85.4)
≥35 y	378 (13.3)	188 (14.6)
BMI, median (range) (kg/m2)	20.7 (19.1–22.9)	20.6 (19.0–22.7)
BMI groups
<18.5	468 (16.5)	231 (18.0)
18.5–23.9	1907 (67.2)	851 (66.2)
≥24	464 (16.3)	203 (15.8)
Race
Han	2750 (96.9)	1240 (96.5)
Minorities	89 (3.1)	45 (3.5)
Education
Primary school or less	271 (9.5)	96 (7.5)
High school	376 (13.2)	165 (12.8)
College	1822 (64.2)	876 (68.2)
Professional or graduate	370 (13.1)	148 (11.5)
Annual household income
<$4000	101 (3.6)	54 (4.2)
$4001–$10,000	408 (14.4)	195 (15.2)
$10,001–$20,000	797 (28.0)	357 (27.8)
$20,001–$40,000	909 (32.0)	430 (33.4)
>$40,000	624 (22.0)	249 (19.4)
Per capita living area, median (range) (m2)	48 (38–60)	47 (39–60)
Occupation
Does not work	531 (18.7)	228 (17.7)
Full-time worker	1776 (62.6)	831 (64.7)
Part-time worker	532 (18.7)	226 (17.6)
Marital status
Married	2799 (98.6)	1271 (98.9)
Single	33 (1.2)	12 (0.9)
Divorced	7 (0.2)	2 (0.2)
Parity
Primiparous	1875 (66.0)	884 (68.8)
Multiparous	964 (34.0)	401 (31.2)
Current smoker
Yes	16 (0.6)	5 (0.4)
Current alcohol consumption
Yes	41 (1.4)	18 (1.4)
Pregnancy complicationsb
Yes	1203 (42.4)	548 (42.6)
ART
Yes	184 (6.5)	68 (5.3)
History of anxiety or depressionc
Anxiety only	10 (0.4)	4 (0.3)
Depression only	6 (0.2)	3 (0.2)
Anxiety and depression	3 (0.1)	2 (0.2)
Confirmed COVID-19 cases in participating Chinese provincesd
<500	1471 (51.8)	647 (50.4)
≥500	1368 (48.2)	638 (49.6)

Data are expressed as median (quartiles) or n (%). Group 1: before the COVID-19 epidemic declaration. Group 2: after the COVID-19 epidemic declaration.

ART, assisted reproductive technology; BMI, body mass index; COVID-19, coronavirus disease 2019;

Wu et al. Depressive and anxiety symptoms in pregnancy during COVID-19 outbreak. Am J Obstet Gynecol 2020.

COVID-19 was incorporated as a notifiable disease in the infection law and health and quarantine law in January 20, 2020, and it was the first time that COVID-19 was reported by official media to spread from human to human. Confirmed COVID-19 and suspected cases have rapidly increased since January 20, 2020

Included gestational diabetes mellitus, preeclampsia, gestational hypertension, intrahepatic cholestasis of pregnancy, placenta previa, malposition, fetal growth restriction, and high-risk pregnancy status

Included generalized anxiety disorder, panic, agoraphobia, posttraumatic stress disorder, social phobia, and depression disorder

Participating Chinese provinces with confirmed COVID-19 cases <500 included Shanghai, Shaanxi, Xinjiang, and Hainan. Provinces with confirmed COVID-19 cases ≥500 included Henan, Zhejiang, Anhui, Hunan, and Jiangxi.

Depressive and anxiety symptoms and coronavirus disease 2019

We found that women in group 2 had higher mean EPDS scores (mean±SD, 7.7±4.4 vs 7.4±4.3) and anxiety subscale scores (mean±SD, 3.4±1.7 vs 3.2±1.7) than those in group 1. Furthermore, awareness of the COVID-19 epidemic significantly increased the prevalence of depressive symptoms (EPDS≥10) (adjusted risk ratio [aRR], 1.20; 95% CI, 1.04–1.40; P=.01) and the risk of thoughts of self-harm (aRR, 2.85; 95% CI, 1.70–8.85; P=.005).

The number of suspected and confirmed COVID-19 cases increased rapidly after human-to-human transmission was first reported on January 20, 2020 (Figure 1 , A and B). Between January 20, 2020, and February 9, 2020, a stable increase in the prevalence of depressive symptoms (EPDS≥10) was found as the number of suspected and confirmed cases increased. Overall, the prevalence of depressive symptoms was 26.0% in group 1 and 29.6% in group 2. Subgroup analysis showed that the frequency of high EPDS scores between January 20 and February 9 was 34.2% (n=81, EPDS≥10) and 13.9% (n=33, EPDS≥13) with the largest increase in symptoms after February 5. To further analyze the adverse effect of the COVID-19 epidemic, standard linear regression models were used to examine the association between depressive symptoms and the number of new infections reported per day. Both number of newly confirmed infections (β=0.09, per 1000 cases increase, P=.003) and suspected infections (β=0.06, per 1000 cases increase, P=.004) per day were positively correlated with the prevalence of depressive symptoms (Figure 1, C and E). A linear positive association was also noted between EPDS scores and the number of newly confirmed infections per day (β=0.09, per 1000 cases increase, P=.04). A significant positive correlation was found between the number of new deaths per day and the prevalence of depression (β=0.05, per 10 cases increase, P=.001) and correlation with EPDS scores (β=0.08, per 10 cases increase, P=.008).

Figure 1

The COVID-19 epidemic characteristics, prevalence of perinatal depression, and association between perinatal depression and daily cases change of COVID-19 infection

A, The increased number of COVID-19 infection confirmed cases and suspected cases. B, The prevalence of perinatal depression change. C–E, Association between confirmed COVID-19, suspected, or death cases and perinatal depression prevalence as predicted prevalence and 95% confidence interval in the whole population. Analyses were adjusted for potential confounders such as age, body mass index, education levels, occupation, annual household income, parity, investigation sites, family support, per capita living area, maternal only-child status, pregnancy complication, and exercise.

COVID-19, coronavirus disease 2019; EPDS, Edinburgh Postnatal Depression Scale.

Wu et al. Depressive and anxiety symptoms in pregnancy during COVID-19 outbreak. Am J Obstet Gynecol 2020.

Risk factors for depressive symptoms

We explored previously identified meta-analytic risk factors and found that in the overall sample, women were at increased risk if they (1) had below college education, (2) had a low annual household income, (3) worked part time or less, (4) had a per capita living area of ≤20 m2, (5) were an only child, (6) had perceived poor family support, (7) reported less than 7 hours per week of physical exercise, and (8) had a placenta previa (Table 2 ).

Table 2

Depression risk factors among the entire sample

Variables	EPDS≥10 n (%)	EPDS<10 n (%)	aRR (95% CIa)	P value
COVID-19–related factors
Investigation time
Jan. 1–20, 2020	739 (26.0)	2100 (74.0)	Ref
Jan. 21–Feb. 9, 2020	381 (29.6)	904 (70.4)	1.20 (1.04–1.40)	.01
Investigation site
Confirmed cases <500	546 (25.8)	1573 (74.2)	Ref.
Confirmed cases ≥500	574 (28.6)	1432 (71.4)	0.96 (0.82–1.11)	.56
Baseline factors
Education
Primary school or less	144 (39.2)	233 (60.8)	Ref.
High school	174 (32.2)	367 (67.8)	0.82 (0.62–1.09)	.18
College	694 (25.7)	2004 (74.3)	0.76 (0.58–0.98)	.04
Professional or graduate	108 (20.8)	410 (79.2)	0.66 (0.47–0.94)	.02
Annual household income
Low (<$10,000)	280 (36.9)	478 (63.1)	Ref.
Middle ($10,001–$40,000)	640 (25.7)	1853 (74.3)	0.70 (0.56–0.84)	<.001
High (>$40,000)	200 (22.9)	673 (77.1)	0.67 (0.53–0.85)	.001
Occupation
Full-time worker	607 (23.3)	2000 (76.7)	Ref.
Does not work	263 (34.7)	496 (65.3)	1.40 (1.15–1.70)	.001
Part-time worker	250 (33.0)	508 (67.0)	1.43 (1.17–1.74)	<.001
Per capita living area
≥20 m2	1029 (26.7)	2832 (73.3)	Ref.
<20 m2	91 (34.6)	172 (65.4)	1.41 (1.07–1.85)	.01
Exercise per wk
≥7 h	240 (24.5)	741 (75.5)	Ref.
<7 h	880 (28.0)	2263 (72.0)	1.23 (1.04–1.46)	.02
Having siblings
No	330 (23.0)	1106 (77.0)	Ref.
Yes	790 (29.4)	1898 (70.6)	1.22 (1.04–1.42)	.01
Family support
Perceived good support from family	15 (0.5)	2989 (99.5)	Ref.
Perceived poor support from family	15 (1.3)	1105 (98.7)	2.33 (1.12–4.86)	.02
Pregnancy complication factors
Placenta previa
No	1028 (26.5)	2846 (73.5)	Ref.
Yes	92 (36.8)	158 (63.2)	1.59 (1.21–2.08)	<.001

aRR, adjusted risk ratio; CI, confidence interval; COVID-19, coronavirus disease 2019; EPDS, Edinburgh Postnatal Depression Scale.

Wu et al. Depressive and anxiety symptoms in pregnancy during COVID-19 outbreak. Am J Obstet Gynecol 2020.

Data are expressed as multivariable adjusted risk ratio (aRR, 95% CI). Multivariate analyses were adjusted for the effects of COVID-19–related factors, baseline factors, and pregnancy complication factors. Other factors including age, parity, body mass index, assisted reproductive technology, and other pregnancy complication factors (gestational diabetes mellitus, preeclampsia, gestational hypertension, intrahepatic cholestasis of pregnancy, malposition, fetal growth restriction, and high-risk pregnancy status) are not significantly associated with perinatal depression and not shown in the table.

A subgroup analysis was conducted to explore risk factors specifically associated with depressive symptoms during the COVID-19 outbreak from January 20, 2020, to February 9, 2020 (Figure 2 ). The contribution of sociodemographic factors to the increased prevalence during the outbreak is shown in Figure 2, B. Women at higher risk for depressive symptoms include those with a middle annual household income and low levels of physical exercise. Interestingly, pregnant women who were primiparous, younger than 35 years, with a per capita area of ≥ 20 m2, and pregestational BMI of ≤18.5 kg/m2 seemed to be more vulnerable to develop depressive symptoms during the COVID-19 outbreak as were those who were employed full time.

Figure 2

Prevalence of perinatal depression and attributable risk proportion in subgroups

A, The prevalence of PND before and after the COVID-19 epidemic declaration Filled circles signify significance in which P<.05. BMI, <18.5 kg/m2; age, <35 years; parity, primiparous; per capita living area, ≥20 m2; annual household income, middle ($10,001–$40,000); occupation, full-time worker; exercise, <7 hours per week. B, ARP and 95% CI of COVID-19 epidemic declaration in subgroups.

ARP, attributable risk proportion; BMI, body mass index; CI, confidence interval; COVID-19, coronavirus disease 2019; PND, perinatal depression.

Wu et al. Depressive and anxiety symptoms in pregnancy during COVID-19 outbreak. Am J Obstet Gynecol 2020.

Discussion

Principal findings

This study examined the relationship between a major life-threatening public health event and maternal mental health wherein there is increased stress and fear due to the additional concern for an unborn fetus. After the declaration of human-to-human transmission of the COVID-19 by the Chinese government on January 20, 2020, global concern and uncertainty increased dramatically. A clinically significant rise in the prevalence of depressive symptoms was found among pregnant women increasing from 26% before January 20, 2020, to 34.2% between February 5 and 9, 2020. A significant increase in anxiety symptoms was also found. The COVID-19 outbreak may contribute to a significant increase in mild depressive symptoms instead of severe symptoms, as we found that the percentage of women with EPDS scores between 10 and 12 was higher after the COVID-19 epidemic declaration (data not shown).

Not surprising, the prevalence of depressive symptoms increased as the number of death and newly diagnosed cases also increased. Owing to the sudden outbreak, the features of the COVID-19 virus and symptoms remained unknown for weeks, causing overall heightened fear and concern for vertical mother-to-fetus transmission among pregnant women. Rapid reporting through the news and social media eliminated the regional differences such that increased rates of depressive symptoms were found among pregnant women in the 10 participating provinces independent of the number of cases found locally.

Results in context of what is known

Consistent with previous meta-analyses, we confirmed several risk factors for depressive symptoms in the whole sample such as low socioeconomic status, insufficient social support, and poor health behaviors including a lack of physical activity. , In addition, maternal only-child status, a common phenomenon in women of reproductive age due to China’s 1-child policy, was found to be an independent risk factor for depression. In the face of the COVID-19 outbreak and the knowledge of human-to-human transmission, subgroup analyses found pregnant women who were younger than 35 years, underweight, primiparous, had middle-income, were working full time, and residing in a per capita living area of ≥20 m2 were now more likely to experience depressive symptoms. These women are not typically at high risk for perinatal mental illness as we identified in the entire study population of pregnant women, and this may help explain the increased rates found in this study after the pivotal date of January 20, 2020. Concern for the economic fallout and increased unemployment caused by the COVID-19 crisis may explain why middle-class women were at increased risk. Conversely, having to leave home to work full time may have increased concern for infection and vertical transmission and thus increased risk for depression and anxiety. A lack of physical activity was continuously associated with depressive symptoms independent of the epidemic. Meta-analytic results suggest physical activity has a protective effect on mental health in young adults. Even small amounts of exercise (eg, walking <150 minutes per week) decreases the incidence of depressive episodes. These findings suggest that 1 potentially modifiable factor for the onset of depression is physical activity and that programs to support exercise across the perinatal period are warranted. In an infectious disease pandemic, exercises performed in isolation or at home may help to decrease the depressive symptoms of pregnant women. For example, home-based exercises, such as walking extra steps around the same rooms inside the flat, or exercising on stairs every few hours could be included as an essential part of the self-isolation or protection guidelines.

Clinical implications

Our present data revealed an increase in the proportion of women with thoughts of self-harm, which could potentially result in death and injury indirectly caused by the COVID-19 outbreak. The interventions for perinatal mental health should be a priority during any public-wide epidemic. Although mental health issues have been acknowledged during pandemics and a guideline of psychological crisis intervention specifically for COVID-19 has been published by the National Health Commission of China, perinatal women have not been highlighted in this guideline as a vulnerable population. Screening for perinatal depression and anxiety has been internationally recommended and should be a priority during an international public health crisis. Under the circumstances of population-based social distancing and isolation, psychological hotlines and online counseling would be a safe and feasible strategy to manage perinatal mental illness. With the limited medical resources, women who have previously experienced perinatal depression could be recruited as trained volunteers to provide telephone-based peer support that has been shown to have a preventive effect.

Research implications

Further intervention studies addressing the screening and management of perinatal mental health through virtual care are warranted. From the SARS experience, we learned that the stressful impact of an infectious disease is qualitatively distinct in 2 ways from the stress of other disasters. First, potential exposure to a contagion brings social isolation. Interpersonal isolation in an infectious disease outbreak results in (1) the required use of personal protective equipment and physical distancing to control the spread of disease, (2) the strong tendency for those who are potentially exposed to cope with significant stress, and (3) the tendency of others to fear, avoid, and stigmatize those who have been potentially exposed. , Second, pregnant women have heightened fear for their unborn fetus’s safety. Given the mental health consequences of a dramatic life-threatening outbreak for pregnant women, organizational and personal resilience strategies should be investigated and may include evidence-based approaches to effective risk communication and the provision of psychological first aid. Clear communication with regular and accurate updates about the outbreak should be provided as preventive strategy for mental well-being. Emotional and behavioral responses are part of an adaptive response to extraordinary stress and psychotherapy techniques such as those based on stress adaptation may be effective. In any public health emergency, feelings of fear, uncertainty, and stigmatization are common and may act as help-seeking barriers to appropriate mental health interventions.

Strengths and limitations

This study is the first to report the mental health response of pregnant women during the COVID-19 outbreak in China. An ongoing multicenter, cross-sectional study to examine the mental health of pregnant women provided a unique opportunity to compare the prevalence of depression before and after the national declaration of an epidemic. Although this innovative study has numerous strengths, it did not include pregnant women from Wuhan, Hubei province. The severe situation and strict quarantine measures in Wuhan owing to the COVID-19 outbreak prevented us from conducting a further study. Another limitation is the assessment of depressive and anxiety symptoms, which relied on a self-reported measure. Although the EPDS and the anxiety subscale is an internationally recommended screening measure and it has been used in numerous studies with Chinese women, it does not provide a diagnosis of depression or anxiety.

Conclusion

This study examined the mental health of pregnant women during the COVID-19 outbreak. Our findings indicate a clinically significant increase in the prevalence of depressive and anxiety symptoms after the declaration of human-to-human transmission and an increased threat of the COVID-19 epidemic. In addition to the well-documented perinatal mental health risk factors, we found that primiparous women of younger age, of middle-income status, and with full-time employment were at increased risk for developing depressive symptoms during the COVID-19 outbreak. More worryingly, the percentage of women with thoughts of self-harm was significantly higher during the outbreak. Our results suggest that effective interventions to manage the mental trauma that developed and potentially continues after serious life-threatening public health events are warranted.